» Articles » PMID: 34140535

Ginsenoside Rg1 Can Restore Hematopoietic Function by Inhibiting Bax Translocation-mediated Mitochondrial Apoptosis in Aplastic Anemia

Overview
Journal Sci Rep
Specialty Science
Date 2021 Jun 18
PMID 34140535
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The present study investigated, the anti-apoptotic activity of Ginsenoside Rg1 (Rg1) via inhibition of Bax translocation and the subsequent recovery of hematopoietic function. Mitochondrial apoptosis in bone marrow mononuclear cells (BMNCs) was observed in aplastic anemia (AA) patients. To establish a mouse model of AA, BALB/c mice were transplanted with lymph node cells from DBA/2 donor mice via vein injection after treatment with Co60 γ-radiation. After treatment with Rg1 for 14 days, the peripheral blood and Lin-Sca-1 + c-Kit + (LSK) cell counts of the treated group were increased compared with those of the untreated model mice. In in vivo and in vitro tests of LSKs, Rg1 was found to increase mitochondrial number and the ratio of Bcl-2/Bax and to decrease damage to the mitochondrial inner and outer membranes, the mitochondrial Bax level and the protein levels of mitochondrial apoptosis-related proteins AIF and Cyt-C by decreasing the ROS level. Rg1 also improved the concentration-time curve of MAO and COX and levels of ATP, ADP and AMP in an in vitro test. In addition, high levels of Bax mitochondrial translocation could be corrected by Rg1 treatment. Levels of markers of mitochondrial apoptosis in the Rg1-treated group were significantly better than those in the AA model group, implying that Rg1 might improve hematopoietic stem cells and thereby restore hematopoietic function in AA by suppressing the mitochondrial apoptosis mediated by Bax translocation.

Citing Articles

Potential of ginsenoside Rg1 to treat aplastic anemia mitogen activated protein kinase pathway in cyclophosphamide-induced myelosuppression mouse model.

Park S World J Stem Cells. 2024; 16(11):900-905.

PMID: 39619872 PMC: 11606349. DOI: 10.4252/wjsc.v16.i11.900.


Protective effect of ginseng extract and total ginsenosides on hematopoietic stem cell damage by inhibiting cell apoptosis and regulating the intestinal microflora.

Liang Z, Gao X, Jing C, Yuan T, Zhang L, Yin Y Int J Mol Med. 2024; 55(1).

PMID: 39513620 PMC: 11573321. DOI: 10.3892/ijmm.2024.5455.


Traditional Chinese medicine for treating aplastic anemia.

Guan J, Zhao Y, Wang T, Fu R J Pharm Pharm Sci. 2023; 26:11863.

PMID: 38022904 PMC: 10679336. DOI: 10.3389/jpps.2023.11863.


Ginsenoside Rg1 as a Potential Regulator of Hematopoietic Stem/Progenitor Cells.

He F, Yao G Stem Cells Int. 2022; 2021:4633270.

PMID: 35003268 PMC: 8741398. DOI: 10.1155/2021/4633270.

References
1.
Zhang Y, Huang N, Xu J, Zheng W, Cui X . Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy. Drug Des Devel Ther. 2020; 14:4749-4763. PMC: 7652225. DOI: 10.2147/DDDT.S279054. View

2.
Ermak N, Lacour B, Drueke T, Vicca S . Role of reactive oxygen species and Bax in oxidized low density lipoprotein-induced apoptosis of human monocytes. Atherosclerosis. 2008; 200(2):247-56. DOI: 10.1016/j.atherosclerosis.2007.12.052. View

3.
Xu S, Yu L, Fan Z, Wu Q, Yuan Y, Wei Y . Improvement of ginsenoside Rg1 on hematopoietic function in cyclophosphamide-induced myelosuppression mice. Eur J Pharmacol. 2012; 695(1-3):7-12. DOI: 10.1016/j.ejphar.2012.07.050. View

4.
Cheng M, Liu L, Lao Y, Liao W, Liao M, Luo X . MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis. Oncotarget. 2016; 7(27):42274-42287. PMC: 5173134. DOI: 10.18632/oncotarget.9786. View

5.
Urao N, Ushio-Fukai M . Redox regulation of stem/progenitor cells and bone marrow niche. Free Radic Biol Med. 2012; 54:26-39. PMC: 3637653. DOI: 10.1016/j.freeradbiomed.2012.10.532. View